Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/18937318

Download in:

View as

General Info

PMID
18937318